J Korean Med Sci.  2020 Aug;35(33):e310. 10.3346/jkms.2020.35.e310.

Proposal of the Autopsy Guideline for Infectious Diseases: Preparation for the Post-COVID-19 Era (abridged translation)

• Kim MY
• Cheong H
• Kim HS

• KMID: 2505600
• DOI: http://doi.org/10.3346/jkms.2020.35.e310

Abstract

With the rapidly spreading coronavirus disease 2019 (COVID-19) pandemic over the past few months, the world is facing an unprecedented crisis. Innumerable lives have been lost to this novel infectious disease, the nature of which supersedes conventional medical understanding. The COVID-19 pandemic is not just a global health crisis, several aspects of life in the post-COVID-19 era are also being contemplated. Experts in unison are warning that the upcoming changes in all areas of life could potentially be far more drastic than ever experienced in the entire human civilization. The medical community is no exception, and therefore, personnel involved in forensic medicine also need to be adequately prepared for the future. Forensic medicine is a branch of medicine dedicated to one of the most important stages of the human lifecycle and has always been at the forefront in times of unprecedented social change. The autopsy, one of the most important tools of forensic medicine, is also useful to infectious diseases because it identifies the causal relationship between death and infection, reveals medical and epidemiological knowledge, and provides objective evidence for legal disputes. We present new autopsy guidelines in forensic medicine, formulated based on the various infectious diseases that we presently live with and may encounter in the future. In formulation of these guidelines several considerations have been taken into account, namely, the role forensic pathologists should play in the post-COVID-19 era and the necessary preparations as well as the support needed from society to fulfill that role. The present COVID-19 outbreak should be a starting point for formulating improvements in current practices in forensic science, including autopsy biosafety practices and the medicolegal death investigation system.

Keyword

Autopsy; Infectious Disease; Guideline; COVID-19; Forensic Medicine

Figure

• 

  Fig. 1 Flow chart of the actions required to protect autopsy personnel after an autopsy, according to the infection status of the body, postmortem test for pathogens and its result, and the presence of suspicious situation for exposure.PPE = personal protective equipment.

Reference

1. Korea Centers for Disease Control and Prevention. Infectious Disease Surveillance Yearbook, 2018. Cheongju: Korea Centers for Disease Control and Prevention;2019.

2. Choe YJ, Choe SA, Cho SI. Trends in infectious disease mortality, South Korea, 1983–2015. Emerg Infect Dis. 2018; 24(2):320–327. PMID: 29350153.

3. The Korean Society of Infectious Diseases. Guidelines for Potential Emerging Infectious Diseases in Korea. Seoul: The Korean Society of Infectious Diseases;2018.

4. Korea Centers for Disease Control and Prevention. Coronavirus disease-19, Republic of Korea. Updated 2020. Accessed May 27, 2020. http://ncov.mohw.go.kr/en.

5. Nolte KB, Taylor DG, Richmond JY. Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002; 23(2):107–122. PMID: 12040252.

6. Centers for Disease Control and Prevention. Interim guidance for collection and submission of postmortem specimens from deceased persons under investigation (PUI) for COVID-19. Updated 2020. Accessed April 27, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html.

7. Osborn M, Lucas S, Stewart R, Swift R, Youd E. Briefing on COVID-19: Autopsy Practice relating to Possible Cases of COVID-19 (2019-nCov, novel coronavirus from China 2019/2020). London: The Royal College of Pathologists;2020.

8. Mao D, Zhou N, Zheng D, Yue J, Zhao Q, Luo B, et al. Guide to forensic pathology practice for death cases related to coronavirus disease 2019 (COVID-19) (Trial draft). Forensic Sci Rev. 2020; 5(1):1–7.

9. Central Disaster Management Headquarters and Central Disease Control Headquarters. Corona Virus Infection-19 Response Guideline. 7-4th ed. Cheongju: Central Disaster Management Headquarters and Central Disease Control Headquarters;2020.

10. Korea Centers for Disease Control and Prevention. Laboratory Guideline for Biosafety. Cheongju: Korea Centers for Disease Control and Prevention;2016.

11. Flavin RJ, Gibbons N, O'Briain DS. Mycobacterium tuberculosis at autopsy--exposure and protection: an old adversary revisited. J Clin Pathol. 2007; 60(5):487–491. PMID: 16731598.

12. Kang JO. Occupational infections of health care personnel in Korea. Hanyang Med Rev. 2011; 31(3):200–210.

13. National Forensic Service. Guideline of Handling Autopsy Samples with Potential MERS Positivity. Wonju: National Forensic Service;2015.

14. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020; 51(9):843–851. PMID: 32222988.

15. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; 92(6):589–594. PMID: 32100876.

16. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382(16):1564–1567. PMID: 32182409.

17. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420–422. PMID: 32085846.

18. Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020; 153(6):725–733. PMID: 32275742.

19. Karami P, Naghavi M, Feyzi A, Aghamohammadi M, Novin MS, Mobaien A, et al. WITHDRAWN: mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings. Travel Med Infect Dis. Forthcoming. 2020; DOI: 10.1016/j.tmaid.2020.101665.

20. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020; 220:1–13. PMID: 32299776.

21. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020; 33(6):1007–1014. PMID: 32291399.

22. Kim SK, Sung H, Kim MN. Kinetic Studies and Infection Control of Respiratory Viruses. Korean J Healthc Assoc Infect Control Prev. 2018; 23(1):1–7.

23. Korean Society for Laboratory Medicine, Korea Centers for Disease Control. Guidelines for the Laboratory Diagnosis of COVID-19 in Korea. 3th ed. Seoul: Korean Society for Laboratory Medicine;2020.

24. National Forensic Service. Safety Guideline for the Autopsy of New Coronavirus Infection. Wonju: National Forensic Service;2020.

25. Henwood AF. Coronavirus disinfection in histopathology. J Histotechnol. 2020; 43(2):102–104. PMID: 32116147.